EMERGENT BIOSOLUTIONS INC. Defined Benefit Plan, Expected Future Benefit Payment, Remainder of Fiscal Year
EMERGENT BIOSOLUTIONS INC. (EBS) had Defined Benefit Plan, Expected Future Benefit Payment, Remainder of Fiscal Year of $12.10 million as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Expected Amounts › Defined Benefit Plan, Expected Future Benefit Payment
us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsRemainderOfFiscalYear · last filed 2020-02-25
- 2019-12-31: Defined Benefit Plan, Expected Future Benefit Payment, Remainder of Fiscal Year $12.10M.
| Period end | Defined Benefit Plan, Expected Future Benefit Payment, Remainder of Fiscal Year |
|---|---|
| 2019-12-31 | $12.10M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |